Weil Company, Inc. Paratek Pharmaceuticals, Inc. Transaction History

Weil Company, Inc.

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 06, 2022	SELL	$2.94 - $4.77 $97,710 - $158,530	-33,235 Closed	0 $0
Q4 2021 Feb 10, 2022	SELL	$4.07 - $5.3 $81,400 - $106,000	-20,000 Reduced 37.57%	33,235 $149,000
Q3 2021 Nov 12, 2021	SELL	$4.7 - $7.24 $7,858 - $12,105	-1,672 Reduced 3.05%	53,235 $259,000
Q1 2021 May 12, 2021	SELL	$6.14 - $8.31 $307,000 - $415,500	-50,000 Reduced 47.66%	54,907 $388,000
Q4 2020 Feb 10, 2021	BUY	$4.58 - $7.14 $3,297 - $5,140	720 Added 0.69%	104,907 $657,000
Q3 2020 Nov 12, 2020	BUY	$4.19 - $6.69 $211,305 - $337,383	50,431 Added 93.81%	104,187 $564,000
Q2 2020 Aug 13, 2020	BUY	$2.97 - $5.22 $74,250 - $130,500	25,000 Added 86.94%	53,756 $281,000
Q1 2020 May 15, 2020	BUY	$2.67 - $4.97 $13,366 - $24,879	5,006 Added 21.08%	28,756 $91,000
Q4 2019 Feb 13, 2020	BUY	$2.93 - $4.5 $10,987 - $16,875	3,750 Added 18.75%	23,750 $96,000
Q3 2019 Nov 13, 2019	BUY	$3.08 - $5.76 $61,600 - $115,200	20,000 New	20,000 $86,000

1.54M

Ticker PRTK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,862,500
Description
Paratek Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of life-saving therapies for life-threatening diseases or other public health threats for civilian, government, and military use. Its lead product candidates include NUZYRA, a once-daily oral and intravenous broad-spectru...

Get notified when there are updates to the investment portfolio of Weil Company, Inc., based on Form 13F filings with the SEC.

Stay updated on Weil Company, Inc. with notifications on news.